Delivering the future of genomic pathogen surveillance
Towards the end of 2019, news first broke of a novel, highly virulent pathogen that could cause serious human respiratory distress and, in some cases, death. That pathogen, SARS-CoV-2, has since been attributed to over 6.5 million deaths and will cost the global economy an estimated $28 trillion in lost output by the end of 2025.
This White Paper reviews how nanopore sequencing overcomes the challenges associated with traditional sequencing technologies to deliver comprehensive, affordable and real-time analysis of human and animal pathogens. Case studies reveal how researchers around the world are now deploying nanopore sequencing to better identify, characterize, and track a range of pathogens to help minimize the threat and impact of disease outbreaks.
In this White Paper, you will learn more about:
- The importance of pathogen surveillance
- The advantages of nanopore sequencing for pathogen surveillance
- Case studies exploring the topic
This content was provided by Oxford Nanopore Technologies
In association with
